Skip to content

Effect of Mitomycin C in intra-operative and post-operative in recurrent, visual acuity and intraocular pressure after pterygium surgery

Effect of Mitomycin C in intra-operative and post-operative in recurrent, visual acuity and intraocular pressure after pterygium surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201207037466N3
Enrollment
120
Registered
2014-06-07
Start date
2010-08-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pterygium. Pterygium

Interventions

Intervention 1: In first group, intraoperative mitomycin C 2% to 3 min and in second group, mitomycin C 2%, four times daily for 2 weeks was used and patients were followed up to 15 months after surge
Treatment - Drugs
In first group, intraoperative mitomycin C 2% to 3 min and in second group, mitomycin C 2%, four times daily for 2 weeks was used and patients were followed up to 15 months after surgery.
mitomycin C 2%, four times daily for 2 weeks
intraoperative mitomycin C 2% to 3 min

Sponsors

Arak University of Medical Sciences, Deputy of Education ad research
Lead Sponsor
Arak University of Medical Sciences
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: inclusion criteria: signed informed consult, indication for pterygium surgery. exclusion criteria: dry eyes, history of vasculitis and collagen vascular diseases.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Recurrence. Timepoint: 1 day, 1 week, 2 weeks, 1 month, 3 months, 6 months, 9 months, 12 months and 15 months after intervention. Method of measurement: Clinical evaluation.

Secondary

MeasureTime frame
Intraocular pressure. Timepoint: 1 day, 1 week, 2 weeks, 1 month, 3 months, 6 months, 9 months, 12 months and 15 months after intervention. Method of measurement: Tonometer application.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Reza Rezaei

Arak University of Medical Sciences

dr.rezaee@arakmu.ac.ir+98 86 3313 4717

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026